How Home Trial Visits Support Sites And Patients

MRN’s Home Trial Support (HTS) and Site Support services are revolutionizing clinical trials by expanding their reach and enhancing diversity. These services enable trials to take place in a wider range of communities, thereby engaging diverse population groups. HTS solutions facilitate participation by allowing patients to engage from home, which reduces logistical costs and time commitments.

By offering personalized care and extending geographical reach, HTS effectively removes traditional barriers to trial participation, leading to improved patient retention. Additionally, this model alleviates staffing challenges at trial sites by enabling healthcare professionals to perform certain procedures in patients' homes. This dual benefit enhances the efficiency and reach of both traditional and mobile trial sites. Overall, HTS and decentralized clinical trial (DCT) approaches are essential for sustaining clinical trials, ensuring participant safety, and accelerating the development of diverse, lifesaving treatments.